Effects of Common CYP1A2 Genotypes and Other Key Factors on Intraindividual Variation in the Caffeine Metabolic Ratio: An Exploratory Analysis

Pharmacokinetic analysis and comparison of caffeine administered rapidly or slowly in coffee chilled or hot versus chilled energy drink in healthy young adults

(2016) John R. White et al.   CLINICAL TOXICOLOGY

Effects of Cytochrome P450 Inhibition and Induction on the Phenotyping Metrics of the Basel Cocktail: A Randomized Crossover Study

(2015) Adrian Derungs et al.   CLINICAL PHARMACOKINETICS

Association between CommonCYP1A2Polymorphisms and Theophylline Metabolism in Non-smoking Healthy Volunteers

(2013) Liqing Wang et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Measurement of CYP1A2 Activity: A Focus on Caffeine as a Probe

(2012) Vidya Perera et al.   CURRENT DRUG METABOLISM

Pharmacokinetic Herb-Drug Interactions (Part 2): Drug Interactions Involving Popular Botanical Dietary Supplements and Their Clinical Relevance

(2012) Bill Gurley et al.   PLANTA MEDICA

Impact of Smoking, Smoking Cessation, and Genetic Polymorphisms on CYP1A2 Activity and Inducibility

(2011) M Dobrinas et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Pharmacokinetics of caffeine in plasma and saliva, and the influence of caffeine abstinence on CYP1A2 metrics

(2011) Vidya Perera et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

PharmGKB summary

(2011) Caroline F. Thorn et al.   Pharmacogenetics and Genomics

Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 −163C>A polymorphism

(2010) Natasa Djordjevic et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Caffeine (1, 3, 7-trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters

(2010) Melanie A. Heckman et al.   JOURNAL OF FOOD SCIENCE

Interactions Between Herbal Medicines and Prescribed Drugs

(2009) Angelo A. Izzo et al.   DRUGS

Influence of genetic polymorphisms, smoking, gender and age on CYP1A2 activity in a Turkish population

(2009) Arzu Gunes et al.   PHARMACOGENOMICS

Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation

(2008) Ulrich M. Zanger et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms

(2008) Arzu Gunes et al.   PHARMACOGENOMICS